ASAITHAMBI ARUNKUMAR enters LANTERN PHARMA INC. with 441.96K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/10/2020ACC: 0001213900-20-014615
441.96K
Baseline shares
100% direct
441.96K
Direct ownership
1 position
43.50K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned441.96K
Total
441.96K direct441.96K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 441.96K | Direct |
| Total | 441.96K | 441.96K direct |
Derivative Holdings1
Option to Purchase
DirectUnderlying security
Common Stock
Underlying shares
43.50K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
43.50K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Option to Purchase Direct | Common Stock | — | — | 43.50K | N/A | |
| Total | 43.50K | 0.00 | ||||